Type to search

F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim | Pharmtech Focus
Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform | Pharmtech Focus
Medtech Accelerator Sofinnova MD Start III Launches a Call for Early Stage Medical Device Projects | Pharmtech Focus